1.1 List of Tables 8
1.2 List of Figures 15

2 Introduction 17
2.1 Cardiovascular Prosthetic Devices Overview 17

3 Products under Development 18
3.1 Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 18
3.2 Cardiovascular Prosthetic Devices - Pipeline Products by Segment 19
3.3 Cardiovascular Prosthetic Devices - Pipeline Products by Territory 20
3.4 Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path 21
3.5 Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date 22
3.6 Cardiovascular Prosthetic Devices - Ongoing Clinical Trials 23

4 Cardiovascular Prosthetic Devices - Pipeline Products under Development by Companies 24
4.1 Cardiovascular Prosthetic Devices Companies - Pipeline Products by Stage of Development 24
4.2 Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 27

5 Cardiovascular Prosthetic Devices Companies and Product Overview 30
5.1 4Tech Cardio Ireland Ltd Company Overview 30
5.1.1 4Tech Cardio Ireland Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
5.2 Abbott Vascular Inc Company Overview 34
5.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 34
5.3 Affluent Medical SA Company Overview 37
5.3.1 Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview 37
5.4 Ample Medical Inc Company Overview 41
5.4.1 Ample Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 41
5.5 Ancora Heart Inc Company Overview 42
5.5.1 Ancora Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.6 Aporo Biomedical, Inc. (Ictive) Company Overview 46
5.6.1 Aporo Biomedical, Inc. (Ictive) Pipeline Products & Ongoing Clinical Trials Overview 46
5.7 AuriGen Medical Ltd Company Overview 47
5.7.1 AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
5.8 BioStable Science & Engineering, Inc. Company Overview 48
5.8.1 BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.9 BioVentrix Inc Company Overview 51
5.9.1 BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 51
5.10 CARAG AG Company Overview 55
5.10.1 CARAG AG Pipeline Products & Ongoing Clinical Trials Overview 55
5.11 Cardiac Dimensions Inc Company Overview 58
5.11.1 Cardiac Dimensions Inc Pipeline Products & Ongoing Clinical Trials Overview 58
5.12 Cardiosolutions Inc Company Overview 61
5.12.1 Cardiosolutions Inc Pipeline Products & Ongoing Clinical Trials Overview 61
5.13 Celyad SA Company Overview 62
5.13.1 Celyad SA Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 Children’s Hospital Boston Company Overview 65
5.14.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 65
5.15 Cierra, Inc. (Ictive) Company Overview 68
5.15.1 Cierra, Inc. (Ictive) Pipeline Products & Ongoing Clinical Trials Overview 68
5.16 Collplant Biotechnologies Ltd Company Overview 69
5.16.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 69
5.17 coramaze technologies GmbH Company Overview 70
5.17.1 coramaze technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 70
5.18 CoreMedic AG Company Overview 71
5.18.1 CoreMedic AG Pipeline Products & Ongoing Clinical Trials Overview 71
5.19 CUBE SRL Company Overview 74
5.19.1 CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview 74
5.20 Daidalos Solutions BV Company Overview 75
5.20.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 75

6 Cardiovascular Prosthetic Devices- Recent Developments 182
6.1 Nov 20, 2019: FDA approves BioVentrix’s Revivent TC system 182
6.2 Nov 20, 2019: LivaNova to restructure its heart valve business line and End Caisson Transcatheter Mitral Valve Replacement Program 182
6.3 Nov 19, 2019: Medtronic reports second quarter fincial results for the year 2019 183
6.4 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 185
6.5 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 186

7 Appendix 287
7.1 Methodology 287
7.2 About GlobalData 290
7.3 Contact Us 290
7.4 Disclaimer 290